Clinical Trial Update: Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological Diseases

View source ↗

Summary

A clinical trial evaluating liposomal amphotericin B in combination with isavuconazole or posaconazole for breakthrough invasive fungal disease in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Disease

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Cresemba (isavuconazole)
• NOXAFIL (POSACONAZOLE)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Invasive Fungal Disease | Status: RECRUITING